HPV Vaccination Qualitative Study: Ethiopia Insights

According to the Enablers and barriers to human papillomavirus vaccination implementation among key stakeholders in Ethiopia: A qualitative study, HPV vaccination implementation in Ethiopia is supported by political commitment, school-based delivery, trusted community voices, and motivated health workers, but remains constrained by misinformation, consent delays, limited resources, donor dependency, and access gaps.

The study shows that qualitative analysis of HPV vaccination is essential because different stakeholder groups experience different barriers: health workers emphasize logistics, parents emphasize fertility rumours, adolescents emphasize peer influence, and pastoralist or urban communities face distinct access and information challenges.

• The 2026 study analyzed six focus group discussions with 42 participants and 19 key informant interviews conducted across Afar, Amhara, Addis Ababa, and Dire Dawa.
• Ethiopia introduced HPV vaccination in 2018 and delivered the vaccine to more than 6.8 million girls during its 2024 nationwide multi-age cohort campaign, according to the study.
• The study identified four broad implementation enablers: adaptable vaccine delivery, supportive policy and partnerships, socio-cultural support, and health system readiness.
• The study identified five broad barriers: suspicions about vaccinating girls aged 9 to 14, misinformation and cognitive resistance, health system constraints, donor dependency, and structural equity gaps.
• The researchers collected data between September 10 and November 30, 2025, and published the peer-reviewed study on November 2, 2026.

The Ethiopia HPV vaccination qualitative study used an interpretive descriptive design to examine how stakeholders understood and experienced implementation. According to the study authors, researchers purposively selected settings representing pastoralist, rural, urban, and geographically diverse contexts.

The study included six focus group discussions with adolescent girls, parents, and community or religious leaders, totaling 42 discussants. The researchers also conducted 19 key informant interviews with healthcare providers, immunization coordinators, administrators, and technical advisors.

According to the study methods, researchers conducted interviews and focus groups in Amharic, transcribed the recordings verbatim, translated the transcripts into English, and checked translations against the original audio and field notes. The researchers analyzed the data using combined deductive and inductive content analysis guided by CFIR 2.0.

The study used two independent coders for two full transcripts, consensus discussions for discrepancies, iterative refinement of the coding framework, and stakeholder feedback on emerging interpretations. These procedures show how qualitative rigor depends on transparent coding, reflexivity, triangulation, and attention to context.

The researchers stated that the study data could not be released publicly because the small samples and identifiable informant roles created a risk of re-identification. The authors made de-identified data available to qualified researchers on reasonable request, subject to institutional review board approval.

The main implication for public health researchers is that HPV vaccination barriers should be analyzed as interconnected implementation problems rather than as isolated knowledge deficits. According to the study, vaccine effectiveness and political support did not eliminate concerns about fertility, sexuality, consent, staffing, cold-chain systems, financing, or geographic access.

Stakeholder segmentation is especially important. According to the researchers, health workers and administrators focused on cold-chain failures, staffing shortages, and coordination gaps; parents and community representatives emphasized fertility rumours and fears about sexual behavior; adolescent girls highlighted peer influence; and participants in pastoralist or displaced communities described mobility and tracking problems.

The findings also show why urban and rural comparisons require nuance. According to the study, urban communities had better proximity to facilities but faced social media misinformation, parental work schedules, and reluctance among some private and international schools. Pastoralist communities faced mobility, distance, and limited fixed infrastructure.

A short quotation from the study captures the value of context-sensitive delivery: one key informant said, "The move to a routinized, single dose and multi-age cohort strategy reduced costs, and made implementation much easier." The same study also records a contrasting operational problem, with a health manager stating, "Cold chain problems and transport delays often cause missed opportunities for vaccination."

Researchers should treat these findings as implementation evidence, not as a clinical recommendation. HPV vaccination decisions require guidance from qualified health authorities, and qualitative findings should be used to improve research, communication, and program design.

The 2026 Ethiopia study demonstrates that HPV vaccination implementation depends on the interaction of trust, policy, delivery systems, financing, workforce capacity, and local access conditions. The study's 42 focus group discussants and 19 key informants provided distinct perspectives that would be difficult to synthesize consistently without structured qualitative analysis.

AI-enabled qualitative research can help public health teams move from disconnected transcripts to transparent themes, stakeholder comparisons, and actionable implementation priorities. Researchers should combine AI-assisted workflows with human validation, ethical data handling, and close attention to cultural and linguistic meaning.

Teams analyzing interviews, focus groups, surveys, or health program documents can start analyzing qualitative data with Evidano.